Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1987 | 1 |
2008 | 1 |
2010 | 1 |
2012 | 1 |
2013 | 1 |
2015 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Apoptosis in chronic cutaneous lupus erythematosus, discoid lupus, and lupus profundus.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7260-5. eCollection 2015.
Int J Clin Exp Pathol. 2015.
PMID: 26261624
Free PMC article.
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A; RECORD-1 Study Group.
Motzer RJ, et al.
Lancet. 2008 Aug 9;372(9637):449-56. doi: 10.1016/S0140-6736(08)61039-9. Epub 2008 Jul 22.
Lancet. 2008.
PMID: 18653228
Clinical Trial.
Item in Clipboard
Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 trial.
Stein A, Bellmunt J, Escudier B, Kim D, Stergiopoulos SG, Mietlowski W, Motzer RJ; RECORD-1 Trial Study Group.
Stein A, et al.
Eur Urol. 2013 Dec;64(6):994-1002. doi: 10.1016/j.eururo.2012.11.032. Epub 2012 Nov 21.
Eur Urol. 2013.
PMID: 23219086
Clinical Trial.
Item in Clipboard
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.
Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Kay A, Ravaud A; RECORD‐1 Study Group.
Motzer RJ, et al.
Cancer. 2010 Sep 15;116(18):4256-65. doi: 10.1002/cncr.25219.
Cancer. 2010.
PMID: 20549832
Free article.
Clinical Trial.
Item in Clipboard
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain S, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Hegemann M, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Del Muro XG, Rodriguez-Vida A, Cicin I, Harputluoglu H, Widau RC, Liepa AM, Walgren RA, Hamid O, Zimmermann AH, Bell-McGuinn KM, Powles T; RANGE study investigators.
Petrylak DP, et al.
Lancet. 2017 Nov 18;390(10109):2266-2277. doi: 10.1016/S0140-6736(17)32365-6. Epub 2017 Sep 12.
Lancet. 2017.
PMID: 28916371
Clinical Trial.
Item in Clipboard
In vitro and in vivo correlates of hybrid tumor resistance.
Stuart PM, Iannaccone PM, Miller SD, Jenkins MK, Del Muro FA, Melvold RW.
Stuart PM, et al. Among authors: del muro fa.
J Natl Cancer Inst. 1987 Jun;78(6):1159-68.
J Natl Cancer Inst. 1987.
PMID: 3495687
Item in Clipboard
Cite
Cite